USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nolangroup SPA

USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A42B (HATS; Head Coverings).

RSS updates for this company

The verdict

According to USPTO PatentsView, Nolangroup ranks #20,163 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 5 technology areas.

#20,163
of 49,997 US assignees by volume
20th percentile
by Innovation Score (26.5/100)
7.1
avg claims per patent
-60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20163 · Foreign Corporation #20,163 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,163/49,997
  • PHOTO-FINISH Ninepoint Medical
  • CPC-NARROW A42B · 5 areas
  • INNOV-THIN 26.5/100
  • CLAIMS-SPARSE 7.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -60% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ninepoint Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nolangroup’s 26.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Nolangroup

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Nolangroup's Innovation Score is 26.5/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Nolangroup?

Each dot is one of Nolangroup’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nolangroup’s own 7.1 claims/patent is at or below the 10.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Nolangroup vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 05101520 Granted patents (volume) Avg claims / patent Ninepoint Medical, Inc. - 14, 17.07Ninepoint MedicalNingbo Lisi Houseware Co., Ltd. - 14, 4.71Ningbo Lisi House…NO Sacrifice Bags Inc. - 14, 6.86NO Sacrifice BagsNOD, Inc. - 14, 18.64NODNorth America I.M.L. Containers Inc. - 14, 4North America I M…Nota, Inc. - 14, 14.71NotaNovasolix, Inc. - 14, 10.36NovasolixNovatek IP, LLC - 14, 18.71Novatek IPNolangroup SPA - 14, 7.07Nolangroup SPA
Nolangroup vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nolangroup's grants concentrate

Nolangroup SPA is a focused PatentsView assignee: 5 CPC subclasses with 50% of grants classified under A42B (HATS; Head Coverings). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2016. By volume, Nolangroup sits between Ninepoint Medical, Inc. and Novatek IP, LLC.

Nolangroup's three-year grant acceleration

Nolangroup SPA shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Nolangroup's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Nolangroup holds 14 patents at rank #20,142, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Nolangroup

By rank, the assignees closest to #20,142 in granted patent volume.

Leaders in A42B (HATS)

Other assignees with the most granted patents in Nolangroup's primary technology class.

Nolangroup's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 20th percentile higher than 20% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2015201620182019202020222023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Nolangroup SPA patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 14.3%
2016 1 7.1%
2018 4 28.6%
2019 3 21.4%
2020 1 7.1%
2022 2 14.3%
2023 1 7.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Nolangroup SPA's patent record in context - here's where to go next.

  • Nolangroup SPA's lead technology class is A42B (HATS; Head Coverings), 50% of its portfolio - see every assignee active in that class. Explore A42B
  • Ranked #20,163 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Nolangroup SPA against Ninepoint Medical, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 26.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.